Concepedia

Jordan Jara

JJ

Statistics

Publications

4

Citations

172

H-Index

4

Active since

2018

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Fondazione IRCCS Istituto Neurologico Carlo Besta

Jordan Jara is an author at Alexion Pharmaceuticals (United States) specializing in myasthenia gravis pharmacotherapy, eculizumab therapy, and pharmacotherapy.

Publications per year

2018–2020

4

Publications

4

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

, , +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

, , +14

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Hiroyuki Murai, Akiyuki Uzawa, Yasushi Suzuki et al. · Journal of the Neurological Sciences · 2019 · 23 citations · Full text

, , +14

A prospective study of benign fasciculation syndrome and anxiety

Alexandra Filippakis, Jordan Jara, Nicholas Ventura et al. · Muscle & Nerve · 2018 · 14 citations

, , +6

1–4 of 4